Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.

Abstract: A method for eliminating bubbles from a liquid dispensing system includes flowing a liquid containing bubbles into a liquid inlet of a tank from a filter to substantially fill the tank, wherein substantially all bubbles accumulate in an upper portion of the tank having a lateral dimension greater than a lateral dimension of a lower portion of the tank, and flowing the liquid into the tank comprises flowing the liquid through an inlet pipe extending at an acute angle relative to a horizontally-oriented axis of the tank. The method further includes flowing a liquid substantially free of bubbles out of the tank via a liquid outlet at the lower portion of the tank for dispensing to a substrate.

Abstract: A semiconductor device includes a single diffusion break (SDB) structure dividing a fin-shaped structure into a first portion and a second portion, an isolation structure on the SDB structure, a first spacer adjacent to the isolation structure, a metal gate adjacent to the isolation structure, a shallow trench isolation (STI around the fin-shaped structure, and a second isolation structure on the STI. Preferably, a top surface of the first spacer is lower than a top surface of the isolation structure and a bottom surface of the first spacer is lower than a bottom surface of the metal gate.

Abstract: Methods for fabricating semiconductor structures are provided. An exemplary method includes forming a first transistor structure and a second transistor structure over a substrate, wherein each transistor structure includes at least one nanosheet. The method further includes depositing a metal over each transistor structure and around each nanosheet; depositing a coating over the metal; depositing a mask over the coating; and patterning the mask to define a patterned mask, wherein the patterned mask lies over a masked portion of the coating and the second transistor structure, and wherein the patterned mask does not lie over an unmasked portion of the coating and the first transistor structure. The method further includes etching the unmasked portion of the coating and the metal over the first transistor structure using a dry etching process with a process pressure of from 30 to 60 (mTorr).

Abstract: Described herein are compounds that are inhibitors of wild type and oncogenic mutant c-KIT kinase and their use in the treatment of disorders such as cancers.

Abstract: Embodiments herein describe techniques for a memory device including at least two memory cells. A first memory cell includes a first storage cell and a first transistor to control access to the first storage cell. A second memory cell includes a second storage cell and a second transistor to control access to the second storage cell. A shared contact electrode is shared between the first transistor and the second transistor, the shared contact electrode being coupled to a source area or a drain area of the first transistor, coupled to a source area or a drain area of the second transistor, and further being coupled to a bit line of the memory device. Other embodiments may be described and/or claimed.

Abstract: Battery packs according to some embodiments of the present technology may include a first longitudinal beam and a second longitudinal beam. The battery packs may include a plurality of cell blocks disposed between the first longitudinal beam and the second longitudinal beam. The plurality of cell blocks may include first and second cell blocks each characterized by a first side surface proximate the first longitudinal beam, a second side surface, a third side surface proximate the second longitudinal beam, and a fourth side surface. The battery packs may include a first interface material thermally coupling the first side surface of the first cell block with the first longitudinal beam. The battery packs may also include a second interface material thermally coupling the third side surface of the second cell block with the second longitudinal beam.

Abstract: Described herein are compounds, such as compounds represented by Formula I-R: and pharmaceutically acceptable salts, enantiomers, stereoisomers, and tautomers thereof, that are inhibitors of GCN2 kinase or PERK kinase, and methods of treating diseases, including diseases associated with GCN2 kinase or PERK kinase, with said compounds.

Abstract: The invention described herein is a very thin flat panel LED luminaire, including a flat baseboard, a flat reflection panel, a flat acrylic panel, a flat diffusion panel, LED bar, and aluminum encasement frame which combines with the baseboard to form the chassis for the luminaire. The LED bar is placed along either or both sides of the stack. The acrylic panel is printed with a mesh-like mask pattern of dots in a pattern in which the density of the pattern is decreases the farther away from the LED bar the pattern is, differentially coupling the light from the point source LED bar from the reflection panel into the flat acrylic panel so that illumination across the luminaire is substantially uniform.

Abstract: The invention described herein is a very thin flat panel LED luminaire, including a flat baseboard, a flat reflection panel, a flat acrylic panel, a flat diffusion panel, LED bar, and aluminum encasement frame which combines with the baseboard to form the chassis for the luminaire. The LED bar is placed along either or both sides of the stack. The acrylic panel is printed with a mesh-like mask pattern of dots in a pattern in which the density of the pattern is decreases the farther away from the LED bar the pattern is, differentially coupling the light from the point source LED bar from the reflection panel into the flat acrylic panel so that illumination across the luminaire is substantially uniform.

Abstract: The disclosure relates generally to an antigenic composition useful for immunization against tularemia. The disclosure is a method for producing a vaccine for preventing tularemia in humans and animals, a new vaccine against tularemia in humans and animals, and a new approach to producing vaccines against tularemia.

Abstract: A device may include a communication interface to communicate with an optical line terminal and a processor. The processor may set an optical path from the optical line terminal to an optical network terminal, the optical path including one or more optical network elements. In addition, the processor may obtain, from the optical line terminal, a status reading of the optical network terminal when the optical path is set. Further, the processor may obtain, from the optical line terminal, a power reading at the optical network terminal when the optical path is set. The processor may record the status reading and the power reading.

Abstract: The disclosure provides an antigenic composition useful for immunization against tularemia. The disclosure provides a method for producing a vaccine for preventing tularemia in humans and animals, a new vaccine against tularemia in humans and animals, and a new approach to producing vaccines against tularemia.

Abstract: The disclosure relates generally to an antigenic composition useful for immunization against tularemia. The disclosure is a method for producing a vaccine for preventing tularemia in humans and animals, a new vaccine against tularemia in humans and animals, and a new approach to producing vaccines against tularemia.

Abstract: A device may include a communication interface to communicate with an optical line terminal and a processor. The processor may set an optical path from the optical line terminal to an optical network terminal, the optical path including one or more optical network elements. In addition, the processor may obtain, from the optical line terminal, a status reading of the optical network terminal when the optical path is set. Further, the processor may obtain, from the optical line terminal, a power reading at the optical network terminal when the optical path is set. The processor may record the status reading and the power reading.

Abstract: The disclosure provides an antigenic composition useful for immunization against tularemia. The disclosure provides a method for producing a vaccine for preventing tularemia in humans and animals, a new vaccine against tularemia in humans and animals, and a new approach to producing vaccines against tularemia.

Abstract: A mechanism is disclosed for assigning repeaters to signal paths in an integrated circuit design. The mechanism involves reserving, in a first metal layer of the integrated circuit design, metal tracks for routing signals. Access points to a plurality of repeaters are reserved in a second metal layer of the integrated circuit design. Each access point is associated with a particular repeater. The design may have other layers between the second metal layer and a region reserved for the repeaters. The number of repeaters may be based on the number of metal tracks that are available to route signals through the first region. Signal paths are assigned routes that comprise at least a portion of one or more of the metal tracks. A route from signal paths requiring a repeater to access points to a particular repeater is determined. Thus, the signal paths are assigned to a repeater.

Abstract: The present invention discloses a system and method for controlling the dispensing of a fine liquid for coating or other applications, by detecting the volume of liquid dispensed when coating a single workpiece and sending a signal to a controller to disable the dispensing when an insufficient volume of liquid is being dispensed. In a preferred embodiment, the fine liquid is spin-on-glass (SOG) used in semiconductor processing machinery during wafer fabrication and the the SOG volume dispensed when coating a semiconductor wafer is measured using a weight measurement instrument, e.g., an electronic scale capable of 0.1 gm. accuracy, which outputs a weight signal that is input, along with a dispenser condition signal from the SOG dispensing machine, to a programmable logic controller (PLC). A set point is selected to produce a desired weight of dispensed liquid, e.g., 1.7 gms. when 2 ccs. are desired, and is programmed into the PLC.

Abstract: The present invention is directed to a method for determining the presence of an oxidant or reductant in a sample by contacting the sample with a thin film of polyaniline in the reduced state or oxidized state, respectively, and measuring the color change occurring with the oxidation or reduction, respectively, of the polyaniline film.